December 30, 2016
1 min read
Save

Lower rate of malalignment found with suprapatellar IM nail insertion technique

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients with distal tibia fractures treated with a suprapatellar intramedullary nailing method had a significantly lower rate of malalignment compared with use of an infrapatellar intramedullary nail technique, according to results.

Researchers categorized 266 patients with tibia fractures into two groups: patients treated using a suprapatellar intramedullary nail (IMN) insertion technique (49.6%); and patients who underwent IMN placement with an infrapatellar technique (50.4%). Researchers measured anatomic alignment of the tibia on anteroposterior and lateral tibia radiographs obtained following surgical fixation.

Hassan R. Mir

Results showed the fibula was intact in 4.5% of patients in the suprapatellar group, fixed in 16.7% and remained fractured in 78.8% compared with 6.7%, 23.9% and 69.4% of patients, respectively, in the infrapatellar group. Researchers found no significant difference in the rate of fibular fixation between the groups.

According to results, 26.1% of patients who underwent infrapatellar IMN insertion experienced primary angular malalignment vs. 3.8% of patients who underwent suprapatellar IMN insertion. While the two groups had no statistical difference in the rate of blocking screws, percutaneous clamp-assisted reduction or provisional plating used, results showed a statistically significant difference when comparing any adjuvant technique vs. no intervention. Researchers found a statistically significant difference in alignment in both the coronal and sagittal planes between the two groups. – by Casey Tingle

Disclosures: Avilucea reports no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.